Гипертрофическая кардиомиопатия с обструкцией выводных отделов правого и левого желудочков сердца.
Сравнение результатов медикаментозного и хирургического лечения
Диссертация
Высокие дозы Р-блокаторов или антагонистов кальция при выраженных формах заболевания не приводят к улучшению показателей систолической и диастолической функций желудочков сердца и в то же время сопровождается многими побочными эффектами. Обструкция выводных отделов обоих желудочков сердца, как правило, сопровождается тяжелой симптоматикой, низкой толерантностью к физической нагрузке и высоким… Читать ещё >
Список литературы
- Бокерия Л. А, Борисов К. В., Синев А. Ф. // Оригинальный способ хирургического лечения гипертрофической обструктивной кардиомиопатии. // Грудная и сердечно-сосудистая хирургия- 1998- № 2, стр. 4−10-
- Бокерия Л. А, Борисов К. В., Синев А. Ф., Савченко Е. Д. Риск внезапной смерти у больных гипертрофической кардиомиопатией. // Грудная и сердечно-сосудистая хирургия- 2001- № 1, стр. 61−70-
- Бокерия Л.А., Борисов К. В., Синев А. Ф. Улучшение диастолической функции левого желудочка сердца после коррекции гипертрофической кардиомиопатии при помощи оригинального способа. // Грудная и серд.-сосуд.хир., 1999, № 6, стр. 130−136-
- Бокерия Л.А., Борисов К. В., Синев А. Ф., Савченко Е.Д Хирургическое лечение гипертрофической кардиомиопатии с обструкцией выводных отделов правого и левого желудочков сердца // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. // 2002- Том 3 № 7. Стр. 8−11-
- Бухарин В. А., Петросян Ю. С., Иваницкая М. А., Оводова Н. Ф. — Кардиология, 1975, № 3, с. 23—30.
- Джанашия П.Х., Круглов В. А., Назаренко В. А., Николенко С. А. // Кардиомиопатии и миокардиты- РГМУ, Москва 2000- стр.8−40-
- Кушаковский М.С. // Хроническая застойная сердечная недостаточность. Идиопатические кардиомиопатии- издательство «Фолиант», Санкт-Петербург, 1998-
- Adelman A. G., Wigle Е. D., Rangdnathan N. et al.—Ann. intern. Med., 1972, vol. 77, p. 515—525.
- Albanesi Filho FM, Castier MB, Lopes AS, Ginefra P: Is the apical hypertrophic cardiomyopathy seen in one population in Rio de Janeiro city similar to that found in the East? Arq Bras Cardiol 1997−69:117−123
- Alexandr C.S., Gobel F.L. Diagnosis of idiopathic hipertrophic subaortic stenosis by right ventricular septal biopsy // Am J of Cardiol- 1974, vol.34: 142 151-
- Asin Cardiel E. Alonso M, Delcan JL, Menarguez L. Echocardiographic sign of right-sided hypertrophic obstructive cardiomyopathy. Br Heart J 1978:40:1321−4.
- Ban- PA. Celermajer JM, Bowdler JD, Cartmill ТВ. Idiopathic hypertrophic obstructive cardiomyopathy causing severe right ventricular outflow tract obstruction in infancy. Br Heart J 1973:35:1109−15.
- M.Basso С., Corrado D., Angelini A., Thiene G. Hypertrophic cardiomyopathy and sudden death in the young: a pathologist’s view. Springer-Verlag Italia, Milano 1998: 52−57-
- Betocchi S., Cannon R.O., Watson R.M. et all. // Circulation 1985- 72:10 011 007-
- Betocchi S., Piscoine F., Losi M.A. et all. // Am J Cardiol 1996- 78:451−457-
- Bigelow W.G., Trimble A.S., Wigle E.D. et all. // J Thorac Cardiovasc Surg- 1974: 68:384−92-
- Bockeria L.A., Borisov K.V., Sinyov A.F. // J Fur Kardioloque, special edition 5/1996, p. 13−14-
- Bockeria L.A., Borisov K.V., Sinyov A.F. // J. Cardiovasc. Surg., 1998, Vol.6, Suppl. 1, p. 25-
- Bockeria L.A., Borisov K.V., Sinyov A.F., Savchenko E.D. // European Heart J 2001, vol 22, abstr. Suppl., p. 93-
- Bockeria L.A., Borisov K.V., Sinyov A.F., Savchenko E.D., Zlotchevskaya E.V. // 12-th World Congress, of ISCTS 2002, abstr., Cardiovascular Engineering, vol 7, № 1, p. 59-
- Botti G, Tagliavini S. Bonatti V, Aurier E. Isolated hypertrophic obstructive cardiomyopathy of the right ventricle. G Ital Cardiol 1979:9:170−81.
- Borggrefe M., Breithart G. Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? JACC Vol.31, № 5, 1998: 1086−1088-
- Borggrefe М., Schwammenthal E., Shulte H.D. Pre- and postoperative electrophysiologic findings in survivors of cardiac arrest and hypertrophic obstructive cardiomyopathy undergoing myectomy. Circulation 1993- 88: 11 201 122-
- Calazel P., Tricoire I., Donzeau J. P. et al.—Arch. Mai. Coeur, 1976, vol. 69, p. 765—776.
- Camerini F., Gavazzi A., De Maria R. // Advances in Cardiomyopathies. Springer-Verlad Italia, Milano 1998, P. 72−76-
- Canedo M.I., Frank M.S. // Am J Cardiol 1981- 48: 383−7-
- Casanova M, Gamallo C, Quero-Jimenez M, Garcia-Aguado A, Burgueros M, Garcia S, Suarez A: Familial hypertrophic cardiomyopathy with unusual involvement of the right ventricle. Eur J Cardiol 1979−9:145−159
- Cecchi F., Maron B.J., Epstein S.E. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989- 13: 1283−1288-
- СессЫ F., Olivotto J., Montereggi A., Squillatini G., Dolara A., Maron B.J. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy. Heart 1998- 79: 125 129-
- Clark C.E., Henry W.N., Epstein S.E. Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis // New Engl J Med 289: 709, 1978-
- Corrado D., Basco C., Schiavon M., Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. The New England Jornal of Medicine Vol. 339, № 6, 1998:364−369-
- Cuiltiere M. — Ann. Cardiol. A-ngeiol., 1980, vol. 29, p. 155—158. •
- Elliot P.M., Sharma S., Varnava A., Poloniecki S., Rowland E., McKenna W.J. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. Am Coll Cardiol 1999- 33(6): 1596−1601-
- Fananapazir L., Epstein N.D., Curiel L.V. // Circulation, 1994, Vol. 90, p. 2731−2742-
- Fananapazir L., Epstein S. E. // Ibid. 1991. — Vol. 67. P. 175−182-
- Fananapazir L., Epstein S.E. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone. Am J Cardiol 1991- 67: 175−182-
- Fananapazir L., Leon M.B., Bonow R.O., Tracy C.M., Cannon R.O., Epstein S.E. Sudden death during empiric amiodarone therapy in simptomatic hypertrophic cardiomyopathy. Am J Cardiol 1991- 67: 169−174-
- Fananapazir L., Leon M. В Bonow R. 0. et al. // Ibid. 1996.- Vol. 14. P. 169 174-
- Fattori R, Rapezzi C, Castriota F, Magnani G, Bertaccini P, Galie N, Magnani B, Gavelli G: Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy. Radio Med (Torino) 1994−88:36−43
- Fiddler</span> С. /., Tajin A. I., Weidman W. A.— et al.— Amer. J. Cardiol., 1978, vol. 42, p. 793—799.
- Flamm M.D., Harrison D.C., Hancock E.W. et all. // Circulation 1968- 38:846 858-
- Fournier C, Bache R, Valette H, Hebert JL, Blondeau M: Hypertrophic myocardiopathy with isolated obstruction of the right ventricle. Ann Cardiol Angeiol (Paris) 1985−34:71−74
- Frustaci A, Chimenti C, Natale L: Right ventricular aneurysm associated with advanced hypertrophic cardiomyopathy. Chest 1998−113:552−554
- Gilligan D.M., Chan W.L., Steward R.A. et all. Am J Cardiol 1991- 68:766 772-
- Gottdiener JS, Gay JA, Maron BJ, Fletcher RD. Increased right ventricular wall thickness in left ventricular pressure overload: echocardio graphic determination of hypertrophic response of the «nonstressed» ventricle. J Am Coil Cardiol 1985:6:550−5.
- Haberer Т., Hess O.M., Jenni R. et all. // Z Kardiol 1983- 72:487−93-
- Harrison E., Sbar S. S., Martin H. et al.—Ibid., 1977, vol. 40, p. 133—136.
- Harrison D.C., Braunvald E., Glick G. et all. // Circulation 1964: 29: 84−98-
- Hopf R., Kaltenbach M. // Z Kardiol 1987- 76 (suppl 3): 137−44-
- Hopf R., Kaltenbach M.// Medical treatment of HCM-
- Jarcho J., McKenna W., Pare J. et al.: Mapping a gene fore familian hypertrophic cardiomyopathy to chromosome 14 ql. N Engl. J. Med. 1990- 321:1372.
- Kuhn H., Loogen F. // Internist 1978- 19: 527−31-
- Lardani H., Serrano I. A., Villamie R. 1.—Ibid., 1978, vol. 41, p. 476—481.
- Loesse В., Loogen F., Schulte H.D. // Z Kardiol, 1987- 76(suppl.3):l 19−30-
- Makhkamova MN: Demonstration of obstruction of blood outflow from the left and right ventricles in idiopathic hypertrophic subaortic stenosis. Kardiologiia 1985−25:52−57
- Maki S., Ikeda H., Muro A., Yoshida N., Shibata A., Koga I., Imaizumi T. Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 1998- 82: 774−778-
- Maron B.J., // Lancet, 1997, Vol. 350, p. 127−133-
- Магоп В.J., Bonow R.O., Cannon R.O. et all. // N Engl J Med 1987- 316: 780 789-
- Maron B.J., Gottdiener J.S., Epstein S.E. Patterns and significance of the distributionof the left ventricular hypertrophy in hypertrophic cardiomyopathy// Am J of Cardiol 48: 418, 1981-
- Maron B.J., Kragel A.H., Roberts W.C. Sudden death due to hypertrophic cardiomyopathy in the absence of increased left ventricular mass. Br Heart J 1990- 63:308−310-
- Магоп В.J., McKenna W.J., Cecchi F. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994- 72: 13−18-
- Maron B.J., McKenna W.J., Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992- 85: 57−63-
- Maron B.J., Roberts W.C., Epstein S.E. Sudden death in hypertrophic cardiomyopathy: profile of 78 patients. Circulation 1982- 65: 1388−1394-
- Магоп B.J., Roberts W.C., McAllister H.A., Rosing D.R., Epstein S.E. Sudden death in young athletes. Circulation 1980- 62: 218−229-
- Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts). N Engl J Med 1987−316:780−789
- Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (second of two parts). N Engl J Med 1987−316:844−852
- Maron BJ, Mcintosh CL, Klues HG, Cannon RO, Roberts WC: Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy. Am J Cardiol 1993−71:1089−1094
- Maron B. J., Roberts W. C., Epstein S. E. // Ibid. 1982 Vol.65 .-P. 1388−1394-
- Maron B.J., McKenna W.J., Cecchi F. // Ibid. 1994-Vol. 72. — P. 13−18-
- Maron B.J., McKenna W.J., Fananapazir L. // Circulation 1992,-Vol. 85.-P. 57−63-
- Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981:48:252−7.
- Matsunaga S, Rikitake N, Yoshioka F, Kata H: Marked right ventricular outflow obstruction in two children with hypertrophic cardiomyopathy. J Cardiogr 1985−15:931−939
- McKenna W., Deanfield J., Faruqui A. et all. // Am J Cardiol 1981- 47:532−8-
- McKenna W.J., Camm A.J. Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation 1989- 80: 1489−1492-
- McKenna W.J., Deanfield J.E. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984- 59: 971−975-
- McKenna W.J., Oakley C.M., Krikler D.M., Goodwin J.F. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachicardia. Br. Heart J 1985- 53: 412−416-
- McKenna WJ, Kleinebenne A, Nihoyannopoulos P, Foale R: Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: Relation to clinical and prognostic features. J Am Coll Cardiol 1988−11:351−358
- McKenna WJ, Krikler DM, Goodwin JF. Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am 1984:68:983−1000.
- McKenna WJ. England D, Doi YL, Deanfield J, Oakley CM. Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy. 1. Influence on prognosis. Br Heart J 1981:46:168−72.
- Pennot C.—Ann. Cardiol. Angeiol., 1980, vol. 29, p. 159—169.
- Pollic C. // N Engl J Med 1982- 307:997−999-
- Pons-Liado G., Carreras F., Borras X. et all. Comparison of morfologic assesment of hypertrophic cardiomyopathy by magnetic resonance imaging versus echocardiographic imaging//Am J of Cardiol- 1997, vol.79: 1651−1656-
- Primo J., Geelen P., Brugada J., Filho A.L., Mont L., Wellens FM Valentino M., Brugada P. Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator. JACC Vol.31, № 5 April 1998: 1086−1088-
- Rosenzweig A., Watkins H., Hwang D. et al.: Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N. Engl. J. Med. 1991- 325:232.
- Sadoul N., Prasad K., Elliot P.M., Bannerjee S., Frenneaux M.P., McKenna
- W.J. Prospective prognostic assessment of blood pressure responce during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997- 96: 2987−2991-
- Satoh R, Okada T, Oimatsu H, Sawai K, Ogawa T, Tuchida A: A case of hypertrophic cardiomyopathy with right ventricular outflow obstruction manifested during three-year follow-up study. Kokyu To Junkan 1990−38:913−917
- Seiler C., Hess O.M., Schoenbech M. et all. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study //JACC Vol 17, № 3, 1991:634−42-
- Seo T, Yokota Y, Kumaki T, Takarada A, Kubo M, Kaku K, Toh S, Fukuzaki H: Regional right ventricular hypertrophy in hypertrophic cardiomyopathy and hypertension. J Cardiogr 1985−15:339−346
- Shah P.M., Adelman A.G., Wigle E.D. et all. // Circ Res 1974: 34/35 (suppl 1 l):ll-179−92-
- Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coil Cardiol 1983:2:437−44.
- Sherrid M." Chu C., Delia E. et al.: An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J. Am Coil. Cardiol. 1993- 22:816.
- Silka M.J., Kron J., Dunnigan A., Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. Circulation 1993- 87: 800−807-
- Simon A. L.—Ibid. 1972, vol. 46, p. 614— 622.'
- Spirito P., Autore C., Rapezzi C. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation 1994- 90: 2743−2747-
- Spirito P., Maron B.J. Relations between extend of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. JACC Vol.15, № 7 June 1990: 1521−1526-
- Spirito P., Seidman C., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. The New England Jornal of Medicine Vol. 336, № 13,1997: 775−785-
- Suzuki J, Chang JM, Caputo GR, Higgins CB: Evaluation of right ventricular early diastolic filling by cine nuclear magnetic resonance imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1991- 18:120— 126
- Tripodi D., McArcavey D., Epstein N.D., Fananapazir L. Impact of the implantable defibrillator in hypertrophic cardiomyopathy patients at high rise for sudden death. J Am Coll Cardiol 1993- 21: 352−355-
- Underson J.E., Bonow R.O., O’Gara P.T. et all. // Circulation 1989- 79:1052−60-
- Von Doenhoff LJ, Nanda NC: Obstruction within the right ventricular body: Two-dimensional echocardiographic features. Am J Cardiol 1983−51:1498−1501
- Von Dohlen TW, Frank MJ: Current perspectives in hypertophic cardiomyopathy: Diagnosis, clinical management, and prevention of disability and sudden cardiac death. Clin Cardiol 1990:13:247−252
- Watkins H., McKenna W., Thierfelder L., et al.: Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N. Engl J.Med. 1995- 332:1158.
- Wigle E.D., Rakowski H., Kimball B.P. et all. // Circulation 1995- 92:16 801 692-
- Wigle E.D., Sasson Z., Henderson M.A. et all. // Prog Cardiovasc Dis 1985- 28: 1−83−5. &
- Wynne J, Braunwald E: The cardiomyopathies and myocarditides. In Heart Disease: A Textbook of Cardiovascular Medicine, Fifth Edition, p. 1414 (Ed. Braunwald E). Philadelphia: WB Saunders Company, 1997
- Yamazaki K, Horimoto M, Igarashi K, Horie T: Hypertrophic obstructive cardiomyopathy in the right ventricle presenting in the elderly woman: A case report. Kokyu To Junkan 1990−38:1165−1169
- Yetman A.T., McCrindle B.W., MacDonald C., Freedom R.M., Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy a rise factor for sudden death. New Engl J Med 1998- 339: 1201−1209.